160 related articles for article (PubMed ID: 1991301)
1. Association of expression between N-myc gene and major histocompatibility complex class I gene in surgically resected human neuroblastoma.
Sugio K; Nakagawara A; Sasazuki T
Cancer; 1991 Mar; 67(5):1384-8. PubMed ID: 1991301
[TBL] [Abstract][Full Text] [Related]
2. Expressions of N-myc and ras oncogene products in neuroblastoma and their correlations with prognosis.
Nakada K; Fujioka T; Kitagawa H; Takakuwa T; Yamate N
Jpn J Clin Oncol; 1993 Jun; 23(3):149-55. PubMed ID: 8350488
[TBL] [Abstract][Full Text] [Related]
3. Competitive polymerase chain reaction for the determination of N-myc amplification in neuroblastoma: report of clinical cases.
Hasan Z; Inoue A; Ikeda H; Kamii Y; Obana K; Yokomori K; Tsuchida Y; Hemmi H; Shimatake H
Eur J Pediatr Surg; 1999 Jun; 9(3):138-41. PubMed ID: 10427487
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical analysis of N-myc protein expression in neuroblastoma: correlation with prognosis of patients.
Hiyama E; Hiyama K; Yokoyama T; Ishii T
J Pediatr Surg; 1991 Jul; 26(7):838-43. PubMed ID: 1895195
[TBL] [Abstract][Full Text] [Related]
5. Lack of N-myc-amplification and normal karyotype in stage IV-N neuroblastoma.
Toren A; Mandel M; Passwell J; Biniaminov M; Neumann Y; Rosenthal E; Kende G; Kenet G; Brok-Simoni F; Rechavi G
Acta Oncol; 1996; 35(4):496-8. PubMed ID: 8695170
[No Abstract] [Full Text] [Related]
6. Expression of the apoptosis-suppressing protein bcl-2, in neuroblastoma is associated with unfavorable histology and N-myc amplification.
Castle VP; Heidelberger KP; Bromberg J; Ou X; Dole M; Nuñez G
Am J Pathol; 1993 Dec; 143(6):1543-50. PubMed ID: 8256847
[TBL] [Abstract][Full Text] [Related]
7. [N-myc gene copies in children with neuroblastoma and its clinical significance].
Ma XL; Gong LP; Zhou CJ; Zhang DW; Jin M; Wang HM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Dec; 20(6):1447-51. PubMed ID: 23257451
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of N-myc oncogene amplification and S-100 protein positivity in children with neuroblastic tumors.
Hachitanda Y; Nakagawara A; Nagoshi M; Tsuneyoshi M
Acta Pathol Jpn; 1992 Sep; 42(9):639-44. PubMed ID: 1476058
[TBL] [Abstract][Full Text] [Related]
9. N-myc amplification in neuroblastomas: histopathological, DNA ploidy, and clinical variables.
Oppedal BR; Oien O; Jahnsen T; Brandtzaeg P
J Clin Pathol; 1989 Nov; 42(11):1148-52. PubMed ID: 2584426
[TBL] [Abstract][Full Text] [Related]
10. Improved survival for patients with advanced neuroblastoma after high-dose combined chemotherapy based in part on N-myc amplification.
Suita S; Tajiri T; Sera Y; Takamatsu H; Mizote H; Nagasaki A; Kurosaki N; Hara T; Okamura J; Miyazaki S; Sugimoto T; Kawakami K; Eguchi H; Tsuneyoshi M
J Pediatr Surg; 2000 Dec; 35(12):1737-41. PubMed ID: 11101726
[TBL] [Abstract][Full Text] [Related]
11. Detection of N-myc amplification in neuroblastomas using Southern blotting on fine needle aspirates.
Barroca H; Carvalho JL; da Costa MJ; Cirnes L; Seruca R; Schmitt FC
Acta Cytol; 2001; 45(2):169-72. PubMed ID: 11284301
[TBL] [Abstract][Full Text] [Related]
12. Stage IVS neuroblastoma: a clinical, histological, and biological analysis of 45 cases.
Hachitanda Y; Hata J
Hum Pathol; 1996 Nov; 27(11):1135-8. PubMed ID: 8912820
[TBL] [Abstract][Full Text] [Related]
13. N-myc oncogene and stage IV-S neuroblastoma. Preliminary observations on ten cases.
Nakagawara A; Sasazuki T; Akiyama H; Kawakami K; Kuwano A; Yokoyama T; Kume K
Cancer; 1990 May; 65(9):1960-7. PubMed ID: 2196987
[TBL] [Abstract][Full Text] [Related]
14. The characteristics of mediastinal neuroblastoma.
Suita S; Tajiri T; Sera Y; Takamatsu H; Mizote H; Ohgami H; Kurosaki N; Hara T; Okamura J; Miyazaki S; Sugimoto T; Kawakami K; Tsuneyoshi M; Tasaka H; Yano H; Akiyama H; Ikeda K
Eur J Pediatr Surg; 2000 Dec; 10(6):353-9. PubMed ID: 11215774
[TBL] [Abstract][Full Text] [Related]
15. Clinical relevance of CD44 cell-surface expression and N-myc gene amplification in a multicentric analysis of 121 pediatric neuroblastomas.
Combaret V; Gross N; Lasset C; Frappaz D; Peruisseau G; Philip T; Beck D; Favrot MC
J Clin Oncol; 1996 Jan; 14(1):25-34. PubMed ID: 8558206
[TBL] [Abstract][Full Text] [Related]
16. Inverse expression of MYCN and mdr-1 in human neuroblastoma.
Nakagawara A; Kadomatsu K; Sato S; Kohno K; Takano H; Kuwano M
Prog Clin Biol Res; 1991; 366():11-9. PubMed ID: 2068131
[No Abstract] [Full Text] [Related]
17. Association of N-myc amplification with neuroblastoma: the Australian and New Zealand experience.
Telford DJ; Kavallaris M; White L; Norris MD; Brian MJ; Stewart BW
J Paediatr Child Health; 1992 Feb; 28(1):58-63. PubMed ID: 1554517
[TBL] [Abstract][Full Text] [Related]
18. Deletion of chromosome 1p loci and microsatellite instability in neuroblastomas analyzed with short-tandem repeat polymorphisms.
Martinsson T; Sjöberg RM; Hedborg F; Kogner P
Cancer Res; 1995 Dec; 55(23):5681-6. PubMed ID: 7585654
[TBL] [Abstract][Full Text] [Related]
19. Expression of neuronal src mRNA as a favorable marker and inverse correlation to N-myc gene amplification in human neuroblastomas.
Matsunaga T; Shirasawa H; Tanabe M; Ohnuma N; Kawamura K; Etoh T; Takahashi H; Simizu B
Int J Cancer; 1994 Sep; 58(6):793-8. PubMed ID: 7523310
[TBL] [Abstract][Full Text] [Related]
20. What is the benefit of aggressive chemotherapy for advanced neuroblastoma with N-myc amplification? A report from the Japanese Study Group for the Treatment of Advanced Neuroblastoma.
Suita S; Zaizen Y; Kaneko M; Uchino J; Takeda T; Iwafuchi M; Utsumi J; Takahashi H; Yokoyama J; Nishihira H
J Pediatr Surg; 1994 Jun; 29(6):746-50. PubMed ID: 8078011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
